Intraday Buy/Sell Signals
Intraday Buy/Sell Signals
Interact to see
Advertisement
Advertisement
CURE vs SPXL
CURE vs SPXL Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
CURE vs. SPXL commentary
Oct 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a Hold and SPXL is a Hold.
SUMMARIES
FUNDAMENTALS
Fundamentals
SPXL has more net assets: 5.41B vs. CURE (182M). SPXL has a higher annual dividend yield than CURE: SPXL (24.556) vs CURE (-1.147). CURE was incepted earlier than SPXL: CURE (14 years) vs SPXL (17 years). SPXL (0.87) has a lower expense ratio than CURE (0.93). SPXL has a higher turnover CURE (23.00) vs CURE (23.00).
| CURE | SPXL | CURE / SPXL | |
| Gain YTD | -1.147 | 24.556 | -5% |
| Net Assets | 182M | 5.41B | 3% |
| Total Expense Ratio | 0.93 | 0.87 | 107% |
| Turnover | 23.00 | 29.00 | 79% |
| Yield | 1.29 | 0.79 | 164% |
| Fund Existence | 14 years | 17 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SPXL | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 84% |
| MACD ODDS (%) | 2 days ago 90% | 2 days ago 84% |
| TrendWeek ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| TrendMonth ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Advances ODDS (%) | 4 days ago 90% | 17 days ago 90% |
| Declines ODDS (%) | 6 days ago 90% | 9 days ago 89% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| REVS | 27.92 | 0.16 | +0.57% |
| Columbia Research Enhanced Value ETF | |||
| UJB | 77.82 | 0.28 | +0.36% |
| ProShares Ultra High Yield | |||
| HYLS | 41.99 | 0.02 | +0.05% |
| First Trust Tactical High Yield ETF | |||
| TBFC | 28.20 | 0.01 | +0.02% |
| The Brinsmere Fund - Conservative ETF | |||
| LITL | 27.86 | N/A | N/A |
| Simplify Piper Sandler Us Small-Cap Plus Income ETF | |||
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been closely correlated with TMO. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if CURE jumps, then TMO could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | +1.89% | ||
| TMO - CURE | 71% Closely correlated | +0.40% | ||
| MTD - CURE | 68% Closely correlated | -0.76% | ||
| DHR - CURE | 67% Closely correlated | -0.88% | ||
| A - CURE | 67% Closely correlated | +0.58% | ||
| PFE - CURE | 67% Closely correlated | +1.16% | ||
More | ||||